GetTopicDetailResponse(id=3a54363e13, topicName=BP180, introduction=BP180, content=null, image=null, comments=1, allHits=1503, url=https://h5.medsci.cn/topic?id=3637, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=39959, tagList=[TagDto(tagId=39959, tagName=BP180)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2105178, encodeId=642921051e81b, content=使用<a href='/topic/show?id=35ce1050e686' target=_blank style='color:#2F92EE;'>#格列汀類#</a>降低<a href='/topic/show?id=c56f43e89eb' target=_blank style='color:#2F92EE;'>#大皰性類天皰瘡#</a>和<a href='/topic/show?id=d20f1090c2' target=_blank style='color:#2F92EE;'>#2型糖尿病#</a>患者的<a href='/topic/show?id=3b941608085' target=_blank style='color:#2F92EE;'>#SDF-1#</a>/<a href='/topic/show?id=8342553e7b' target=_blank style='color:#2F92EE;'>#CXCL12#</a>水平，但不增加<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>抗<a href='/topic/show?id=3a54363e13' target=_blank style='color:#2F92EE;'>#BP180#</a>的<a href='/topic/show?id=39998636197' target=_blank style='color:#2F92EE;'>#自身抗體#</a>水平。<a href='/topic/show?id=2c679051240' target=_blank style='color:#2F92EE;'>#西格列汀#</a>，這項(xiàng)研究有意思, objectTitle=Front Immunol：使用格列汀降低大皰性類天皰瘡和2型糖尿病患者的SDF-1/CXCL12水平，但不增加糖尿病患者抗BP180的自身抗體, objectType=article, longId=739441, objectId=f6efe39441ca, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/114.jpg, objectUrl=/article/show_article.do?id=f6efe39441ca, replyNumber=0, likeNumber=257, createdTime=2022-12-10, rootId=0, userName=lifestar, userId=aa0e14, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f6efe39441ca, moduleTitle=Front Immunol：使用格列汀降低大皰性類天皰瘡和2型糖尿病患者的SDF-1/CXCL12水平，但不增加糖尿病患者抗BP180的自身抗體, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f6efe39441ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
